CatalystPit

LLYELI LILLY & Co

NYSE · Pharmaceutical Preparations
Last close $1169.60 · 2026-10-08
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$1.09T
RECENT INSIDER TRADES
  • 2026-09-22 · LUCIANO JUAN R (Director) · OTHER
  • 2026-09-22 · Alvarez Ralph (Director) · OTHER
  • 2026-09-22 · Sulzberger Gabrielle (Director) · OTHER
  • 2026-09-22 · Fyrwald J Erik (Director) · OTHER
  • 2026-09-11 · Seymour Melissa (EVP, Global Quality) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders5,035
Shares held952,265,081
Value$1.07T
Percent of shares outstanding101.16%
As of quarter end2026-09-30
RECENT CONGRESSIONAL TRADES
  • 2026-07-01 · Michael Rulli · SELL · $1,001 - $15,000
  • 2026-06-10 · Gilbert Cisneros · BUY · $50,001 - $100,000
  • 2026-06-02 · Ro Khanna · BUY · $1,001 - $15,000
  • 2026-04-08 · Hon. Elizabeth Fletcher · SELL · $1,001 - $15,000
  • 2026-04-02 · Byron Donalds · BUY · $1,001 - $15,000
RECENT NEWS
  • Combining Eli Lilly's Taltz with Zepbound could enhance psoriasis, metabolic benefits
  • Eli Lilly: Weight-Loss Money Machine Isn't Slowing Down
  • Eli Lilly's Taltz and Zepbound show broader biomarker changes in psoriasis-obesity study
  • Eli Lilly and the LA Dodgers: A tale of 2 dynasties
  • Eli Lilly, Glaukos among market cap stock movers on Thursday
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS